Prevalence of dysphagia in patients with multiple sclerosis: A systematic review and meta-analysis

被引:11
|
作者
Mirmosayyeb, Omid [1 ,2 ]
Ebrahimi, Narges [2 ]
Shekarian, Arman [2 ]
Afshari-Safavi, Alireza [3 ]
Shaygannejad, Vahid [1 ,2 ]
Barzegar, Mahdi [1 ,2 ]
Bagherieh, Sara [2 ]
机构
[1] Isfahan Univ Med Sci, Sch Med, Dept Neurol, Esfahan, Iran
[2] Isfahan Univ Med Sci, Isfahan Neurosci Res Ctr, Esfahan, Iran
[3] North Khorasan Univ Med Sci, Fac Hlth, Dept Biostat & Epidemiol, Bojnurd, Iran
关键词
Multiple sclerosis; Dysphagia; Prevalence; QUALITY-OF-LIFE; OROPHARYNGEAL DYSPHAGIA; DYMUS QUESTIONNAIRE; PERSIAN VERSION; VALIDATION; MS; SPEECH; VIDEOFLUOROSCOPY; DISEASE; IMPACT;
D O I
10.1016/j.jocn.2023.01.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Dysphagia is a major disorder observed in patients with multiple sclerosis (MS), yet different prevalence rates are reported for it. Therefore, we designed this study to estimate the pooled prevalence of dysphagia in patients with MS. Method: We searched PubMed, Scopus, EMBASE, Web of Science, and gray literature including references from the identified studies, reviews studies, and conference abstracts which were published up to May 2022. Articles that were relevant to our topic and could provide information regarding the prevalence of dysphagia among MS patients were included; however, articles with self-report screening strategies were excluded. Results: The literature search found 997 articles. After eliminating duplicates, 672 articles remained. Two conference abstracts were included for final analysis. A total of 11,266 MS cases and 5047 MS patients with dysphagia were included in the meta-analysis. The overall prevalence of dysphagia across all 54 studies was 44.8 % (95 % CI: [40.4 %-49.2 %]), with a high level of heterogeneity between countries (Q=; I2 = 94.96 %; p < 0.001). Conclusion: The results of this systematic review shows that the prevalence of dysphagia in MS patients is 45% which is greatly higher compared to the general population.
引用
收藏
页码:84 / 94
页数:11
相关论文
共 50 条
  • [41] Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis
    Mirmosayyeb, Omid
    Ebrahimi, Narges
    Barzegar, Mahdi
    Afshari-Safavi, Alireza
    Bagherieh, Sara
    Shaygannejad, Vahid
    PLOS ONE, 2022, 17 (04):
  • [42] Cannabinoids for spasticity in patients with multiple sclerosis: A systematic review and meta-analysis
    Azadvari, Mohaddeseh
    Pourshams, Maryam
    Guitynavard, Fatemeh
    Emami-Razavi, Seyede Zahra
    Taftian-Banadkouki, Ensieh
    Ghajarzade, Mahsa
    Rastkar, Mohsen
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2024, 10 (04)
  • [43] Prevalence of depression in multiple sclerosis: a review and meta-analysis
    Even, C
    Friedman, S
    Dardennes, R
    Zuber, M
    Guelfi, JD
    REVUE NEUROLOGIQUE, 2004, 160 (10) : 917 - 925
  • [44] The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
    Moghadasi, Abdorreza Naser
    Mirmosayyeb, Omid
    Barzegar, Mahdi
    Sahraian, Mohammad Ali
    Ghajarzadeh, Mahsa
    NEUROLOGICAL SCIENCES, 2021, 42 (08) : 3093 - 3099
  • [45] The prevalence of inflammatory bowel disease (IBD) in patients with multiple sclerosis (MS): A systematic review and meta-analysis
    Nasirzadeh, Amirreza
    Jahanshahi, Reza
    Ghajarzadeh, Mahsa
    Mohammadi, Aida
    Moghadasi, Abdorreza Naser
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2023, 14 (01) : 81
  • [46] The prevalence of cancer in patients with multiple sclerosis (MS) who received rituximab: a systematic review and meta-analysis
    Mirmosayyeb, O.
    Shaygannejad, V.
    Ebrahimi, N.
    Ghoshouni, H.
    Ghajarzadeh, M.
    NEUROLOGIA, 2025, 40 (01): : 41 - 47
  • [47] The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): A systematic review and meta-analysis
    Ghajarzadeh, Mahsa
    Moghadasi, Abdorreza Naser
    Mirmosayyeb, Omid
    Barzegar, Mahdi
    Sahraian, Mohammad Ali
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [48] The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
    Abdorreza Naser Moghadasi
    Omid Mirmosayyeb
    Mahdi Barzegar
    Mohammad Ali Sahraian
    Mahsa Ghajarzadeh
    Neurological Sciences, 2021, 42 : 3093 - 3099
  • [49] Incidence, prevalence, and characteristics of heart failure among patients with multiple sclerosis: A systematic review and meta-analysis
    Bagherieh, Sara
    Ghoshouni, Hamed
    Bostan, Fatemeh
    Afshari-Safavi, Alireza
    Badihian, Shervin
    Barzegar, Mahdi
    Shaygannejad, Vahid
    Mirmosayyeb, Omid
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 59
  • [50] Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis
    Ramsenthaler, Christina
    Kane, Pauline
    Gao, Wei
    Siegert, Richard J.
    Edmonds, Polly M.
    Schey, Stephen A.
    Higginson, Irene J.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (05) : 416 - 429